300677 英科医疗
2024/06 - 中期
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入4,512,06936.94%6,918,7246,613,81416,240,09413,836,715
减:营业总成本3,933,66230.94%6,753,5606,051,3327,580,9255,472,759
    其中:营业成本3,524,05119.74%5,971,0235,745,7176,251,6264,285,310
               财务费用(196,110)-57.10%(306,436)(627,253)(19,180)265,411
               资产减值损失(9,608)1,310.02%(5,349)(44,038)(5,744)(1,434)
公允价值变动收益65,360-26.36%175,56759,67032,6613,176
投资收益46,141-11.04%87,44683,27128,4584,710
    其中:对联营企业和合营企业的投资收益------------
营业利润668,05450.34%438,990707,1848,688,7258,368,929
利润总额663,18256.18%442,818704,4148,648,6938,346,638
减:所得税费用71,238-40.70%54,75365,0711,185,2211,342,127
净利润591,94394.41%388,065639,3437,463,4717,004,511
减:非控股权益4,916-56.61%5,06710,27333,395(2,537)
股东净利润587,027100.24%382,998629,0707,430,0767,007,048

市场价值指针
每股收益 (元) *0.900104.55%0.5800.95011.33014.650
每股派息 (元) *0.050--0.0800.1000.7503.500
每股净资产 (元) *25.5755.16%24.43423.96528.87926.498
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容